An antioxidant probiotic reduces postprandial lipemia and oxidative stress
- 200 Downloads
Reducing postprandial oxidative stress (OxS), decreasing postprandial blood triglyceride level (TG) and improving lipoprotein status is likely to have a preventive impact on the development of cardiovascular disease (CVD). Previously we have shown that the antioxidant probiotic Lactobacillus fermentum ME-3 (DSM14241) is characterized by antiatherogenic effects. This randomized double-blind placebo-controlled study evaluated the influence of kefir enriched with an antioxidative probiotic L. fermentum ME-3 (LfKef) on postprandial OxS, blood TG response and lipoprotein status. 100 clinically healthy subjects were recruited into the study. Blood parameters of postprandial OxS, TG and lipoprotein status were determined by oxidized LDL, baseline diene conjugation in LDL (BDC-LDL), oxidized LDL complex with beta-2 glycoprotein (Beta2-GPI-oxLDL), paraoxonase (PON) activity, LDL-Chol, HDL-Chol and TG. To evaluate general body postprandial OxS-load we measured 8-isoprostanes (8-EPI) in the urine. Consumption of LfKef significantly reduced the postprandial level of oxidized LDL, BDC-LDL, Beta2-GPI-oxLDL, urinary 8-isoprostanes and postprandial TG and caused a significant increase in HDL-Chol and PON activity. This is the first evidence that kefir enriched with an antioxidant probiotic may have a positive effect on both postprandial OxS and TG response as well as on lipoprotein status.
KeywordsPostprandial period Oxidative stress Postprandial lipemic response Probiotics Lactobacillus fermentum Oxidized low-density lipoprotein Paraoxonase, isoprostanes
Unable to display preview. Download preview PDF.
- Perez-Martinez P., Ordovas J.M., Garcia-Rios A., Delgado-Lista J., Delgado-Casado N., Cruz-Teno C., et al., Consumption of diets with different type of fat influences triacylglycerols-rich lipoprotein particle number and size during the postprandial state, Nutr. Metab. Cardiovasc. Dis., In press, DOI: 10.1016/j.numecd.2009.07.008Google Scholar
- Salminen S., Human studies on probiotics. Aspects of scientific documentation, Scand. J. Nutr., 2001, 45, 8–12Google Scholar
- Songisepp E., Kals J., Kullisaar T., Mändar R., Hütt P., Zilmer M., et al., Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers, Nutr. J., 2005, 20, 4–22Google Scholar
- Kullisaar T., Mikelsaar M., Kaur S., Songisepp E., Zilmer K., Hütt P., et al., Probiotics, oxidative stress inflammation and diseases, In: Curic D., (Ed.), Proceedings of the Joint Central European Congress (15-17 May 2008 Cavtat, Croatia), Croatian Chamber of Economy, 2008, 1, 367–373Google Scholar
- Stsepetova J., Kullisaar T., Songisepp E., Zilmer M., Mikelsaar M., Design of L. fermentum ME-3 strain-specific primers for detecting the cell number in human feces by real-time PCR., Gastroenterol. Sankt-Peterburg, 2009, 4, A26–A27, (in Russian)Google Scholar
- Dzau V.J., Antman E.M., Black H.R., Hayes D.L., Manson J.E., Plutzky J., et al., The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease), Circulation, 2006, 114, 2850–2870CrossRefPubMedGoogle Scholar
- Halliwell B., Gutteridge J.M.C., (Eds.), Free radicals in biology and medicine, 3rd Ed., Oxford University Press, New York, 1999Google Scholar
- Truusalu K., Mikelsaar R.-H., Naaber P., Karki T., Kullisaar T., Zilmer M., et al., Eradication of salmonella Typhimurium infection in a murine mudel of tophoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin, BMC Microbiol., 2008, 8, 132–136CrossRefPubMedGoogle Scholar
- Hansel B., Giral P, Nobecourt E., Clantepie S., Bruckert E., Chapman M.J., et al., Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity, J. Clin. Endocrin. Met., 2006, 89, 4963–4971CrossRefGoogle Scholar
- Durrington P.N., Mackness B., Mackness M.I., Paraoxonase and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 2005, 21, 473–480Google Scholar